INOD in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with INOD today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Companies developing AI need data to train their models and ways to check how those models behave before putting them to work. Innodata prepares training data, helps refine model responses, tests capabilities and safety, and supports deployment. It combines specialist staff with software that automates work and keeps people involved in quality checks. Customers pay for agreed projects and programs, with the scope and pricing set in individual orders. Its Digital Data Solutions business supplies most of its revenue, and major technology companies and AI model developers are important customers.
Innodata depends heavily on one customer that accounts for most of its revenue. Customers generally have no obligation to buy future services and can terminate engagements, so continued work depends on their project needs and funding. Because Innodata handles confidential and personal data, privacy and security laws and customer contracts restrict how it may use and disclose that information.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Innodata depends on AI developers’ project spending, with one unnamed customer supplying 58% of revenue, while closer AI-data rivals Appen, Scale AI and Surge AI are missing from this list.
TaskUs, Inc. competes with Innodata for technology and AI customers paying for human-supported AI work and trust-and-safety services. Watch its AI Services revenue rather than its larger customer-service business for a closer read on the spending Innodata targets.
ExlService Holdings, Inc. competes with Innodata for clients paying to organize data and put AI into business workflows, including insurers. EXL’s work for life and disability insurers is worth watching alongside Innodata’s Synodex platform, which turns medical records into structured information for insurance and healthcare workflows.
Accenture competes with Innodata for enterprise spending on preparing data and putting AI systems into use, through consulting and services that run work for clients. Its AI deployment engagements are the relevant overlap; Accenture’s wider consulting business is less specific to Innodata.
Cognizant competes with Innodata for enterprise clients paying for AI, connecting technology systems and outsourced business services. Watch its tailored AI solutions and integration work for the overlap with Innodata’s model deployment and integration services.
Genpact competes with Innodata for enterprises paying outside providers to manage data and bring AI into business workflows. Its work for banking and insurance clients offers a concrete area to watch, since Innodata also serves those customers.
Infosys competes with Innodata for enterprises paying for data, AI and technology implementation, but its services business is much broader. Focus on its data and AI work rather than treating its cloud, cybersecurity and other services as a direct guide to Innodata.
TELUS competes with Innodata through TELUS Digital, which sells AI data and trust-and-safety services to clients, but its telecommunications operations dilute that exposure. Watch TELUS Digital’s AI and data solutions rather than mobile and internet service revenue for the relevant competitive signal.
ExlService Holdings, Inc. earningsEXLS
ExlService Holdings’ report will show whether insurers are still paying for data organization and AI-enabled workflows, spending that overlaps with Innodata’s Synodex business.
Focus on ExlService Holdings’ work for life and disability insurers, not its whole business as a direct proxy for Synodex. Strength there would suggest insurers are still funding data and workflow projects, supporting demand for Innodata’s medical-record structuring service; weakness would point to tighter spending and a harder path for Synodex to win or retain work.
Innodata Inc. earningsThis company
DDS brings in most of Innodata’s revenue, and one customer accounts for a large share; this report will show whether more AI data-services work is adding gross profit without deepening that dependence.
Read DDS revenue and gross margin alongside the largest customer’s share of revenue. Rising DDS sales with a stable or higher margin would show new work is covering delivery costs; slower sales or a lower margin would point to weaker project volume or direct costs rising faster than revenue. If the largest customer’s share grows, even stronger results would leave revenue more exposed to that customer cutting or ending work.